leisure time -WSS

leisure time

author：comprehensive 2025-08-12 08:30:11 - browse：338

A pharmacist hands a box of Wegovy — first opinion coverage from STAT — Bloomberg photo by George Frey

LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of its blockbuster obesity drug Wegovy for new patients in the United States, after massive demand and a supply crunch had led it to limit doses last May.

The announcement that Novo was making more of its lower-dose starter product available as of this month came as the company reported its 2023 earnings, with sales up by 36% and operating profit up 44% at constant exchange rates, driven by enormous sales of Wegovy and Ozempic, the company’s sister drug for diabetes. The company also projected double-digit growth in sales and operating profit for 2024.

“I am pleased to state that we are now enabling more new U.S. patients to initiate treatment by more than doubling the amount of lower-dose strength Wegovy compared to previous months,” Novo CEO Lars Fruergaard Jørgensen said on a call with reporters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： What is microchimerism and how does it affect maternal health?

WSS

How neuroscience research could help beat back brain cancer

Johnson & Johnson sues to stop Medicare negotiation

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Twill hunts for pharma partner to market its depression app

Johnson & Johnson sues to stop Medicare negotiation

After Sarepta trial failure, Duchenne families brace for more debate

hotspot

leisure time

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

In age of alternative facts, a scholarly course on calling out crap

Biden administration sends mixed signals on US soldier who crossed into North Korea

The cancer drug shortage isn’t new — and neither are the solutions

How neuroscience research could help beat back brain cancer

Sports medicine is finally prioritizing gender equality

US soldier in North Korean custody after crossing DMZ line

Sports medicine is finally prioritizing gender equality

ER docs worry over extreme heat as a 'mass casualty event'

hotspot

BridgeBio heart drug succeeds in pivotal study

Infant mortality in U.S. rose last year for first time in decades: CDC

How to convince healthy people to buy insurance

Infant mortality in U.S. rose last year for first time in decades: CDC

Robert Kennedy Jr.'s presidential campaign attracts GOP

DeepMind touts AlphaFold's new skills as protein folding AI models face off

entertainment

leisure time

focus

hotspot